Navigation Links
J. Greg Davis Appointed President & Chief Executive Officer of Tryton Medical, Inc.
Date:4/28/2008

RESEARCH TRIANGLE PARK, N.C., April 28 /PRNewswire/ -- Tryton Medical, Inc. announced today that it has appointed J. Greg Davis as President and Chief Executive Officer. Founded in 2003, Tryton Medical is the leading developer of stents that are designed to definitively treat bifurcation lesions.

Mr. Davis joins Tryton Medical after a successful 20-year career with Guidant and Eli Lilly & Company. Mr. Davis is an experienced medical device executive with broad global and functional experience in finance, manufacturing, sales and general management. Most recently he was president of Guidant, Japan with profit and loss responsibility for the company's $225 million cardiovascular business. Prior to his work in Japan, Mr. Davis managed Guidant's product portfolio in 13 Asian countries. Mr. Davis earned a BS in Mechanical Engineering from The University of Minnesota and an MBA from The University of Michigan.

"I am excited about this opportunity because I believe the Tryton Side-Branch Stent(TM) will redefine the standard of care for bifurcation lesions," said Mr. Davis. "Tryton's elegant design, ease-of-use and stellar clinical results are impressive. I look forward to implementing the company's aggressive European commercialization strategy and U.S. clinical trial plans."

"We are delighted to welcome Greg to Tryton Medical during this pivotal time in the company's development," said Dan Cole, Co-Founder and Board Member of Tryton and General Partner of Spray Venture Partners. "We believe his proven track record of growing successful businesses and achieving results will enable Tryton to capitalize on its leadership position in the industry."

"Greg's rich international experience and customer focus will be real assets as we launch the Side-Branch Stent(TM) across Europe," said Rick Anderson, Board Member of Tryton and Managing Director of PTV Sciences, and former Company Group Chairman, Cordis Corporation. "The Tryton 1 (First in Man)
'/>"/>

SOURCE Tryton Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. NCRA Urges U.S. Reps. Danny Davis and Judy Biggert to Approve in Conference the Higher Education Reauthorization Bill Providing Closed Captioning for 30 Million Deaf and Hard-of-Hearing Americans
2. Boston Kids Enjoy Free Davis Vision Screenings
3. Davis Vision, United Concordia Free Clinic Promotes Childrens Eye and Dental Health
4. TeamStaff Hires Jeff Davis as Director of Operations for Government Solutions Subsidiary
5. Sex & the City Gets Serious About HIV and AIDS in South Africa - Kristin Davis Helps Oxfam Break the Stigma and Close the Treatment Gaps Fuelling AIDS
6. Congressman Davis to Tour Pathology Laboratory, Learn Critical Role in Patient Care
7. New UC Davis study finds physician style and HMO affiliation impact lengths of patient visit
8. UC Davis researchers identify a cellular pathway that makes prostate cancer fatal
9. UC Davis researchers discover novel pathway to increased inflammation in diabetes patients
10. UC Davis researchers find evidence of mature heart cell potential in embryonic stem cells
11. After Dropping 162 Pounds, Jodi Davis Inspires Other Michigan Women to Get Moving and Lose Weight Through WalkyTalk.com(TM)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... 3 The following is bei..., U.S. Senate Judiciary Committee Chairman Patr...health care reform bill that would repeal the heal...tions such as price fixing, bid rigging and market...es the repeal, which would subject health insuranc...
(Date:12/3/2009)...n 1,500 Jobs Listed through APHA,s Public Health C...-USNewswire/ -- Today,s White House jobs summit re...ny professions, including public health. One publi...ect job seekers to more than 1,500 jobs in the hea...://www.apha.org/about/careers/ is a full online c...
(Date:12/3/2009)...ches rzteblatt International contains the first s...h the novel influenza A virus (H1N1/09) in the Ger...emic. Ralf Winzer and his coauthors from the Dssel... data from a large clinical cohort of infected per...: 770-6). Their medical-scientific article is acco...
(Date:12/3/2009)...atori World Medical, a leading global healthcare c... space, announced that international medical quali...Medical Quality Advisory Board (MQAB). , ...2009 –- Satori World Medical, a leading glob... medical travel space, announced that internationa...
(Date:12/3/2009)...wed, the more likely they were to light up, study ...ws) -- Seeing movie characters smoke cigarettes in...try smoking, according to a new study that calls f...ng. , It followed 1,328 Mexican-American adoles... types of movies they viewed. , At the start of...
Breaking Medicine News(10 mins):Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 2Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 3Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 4Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 5Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 6Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 7Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 8Health News:Public Health Jobs Site Available to Help Meet Growing Demand 2Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 2Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 3Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 4Health News:Movies May Tempt Teens to Smoke 2
...ts positive or negative emotional state has no dir...se progression, according to a large scale new stu...CER, a peer-reviewed journal of the American Cance...f whether or not the mind, through psychological s...
...t. 20 Nearly eight years of planning and,preparat...ted move from the,existing facility into the new s... one million square foot hospital brings together ...oncology and,obstetrics, the hospital offers care ...
...age of that extra hour of snooze-time, experts say... When the clocks go back an hour on the first Sund...make a small payment on your sleep debt, experts s...Stanford University Medical Center in Palo Alto, C...
... Oct. 19 Following is a statement,by Linda A. Suy...Products,Association (CHPA), regarding the recomme...ministration,s Nonprescription Drugs Advisory Comm...children., "For decades, parents and other caregi...
...ct. 19 A new survey released by the National,Alli...ic parents are,unaware of available resources for ...are of where to seek help for ADHD compared to,non...l Alliance for Hispanic Health,at: http://media.m...
... D. and Catherine T. MacArthur Foundation has prom...SF project to help combat maternal mortality in Ni...hird of all maternal deaths worldwide. , MacArth...ental organization Pathfinder International, which...
Other Medicine News:Health News:Cancer survival is not influenced by a patient's emotional status 2Health News:Northwestern Memorial Hospital Completes Move Into Its New Prentice Women's Hospital 2Health News:Northwestern Memorial Hospital Completes Move Into Its New Prentice Women's Hospital 3Health News:Fall Time Change Could Be Boon for Sleep 2Health News:Statement from the Consumer Healthcare Products Association on Today's Joint FDA Advisory Committee Recommendations Regarding Pediatric Over-the-Counter Cough and Cold Medicines 2Health News:MacArthur commits $11 million to further UCSF work in maternal safety 2Health News:MacArthur commits $11 million to further UCSF work in maternal safety 3
(Date:12/3/2009)...TER, N.Y., Dec. 3 Virtua...er of quantitative imaging for clinical trials, an...ethod for 4D Reconstruction and Visualization" rec...pics, Vice President of Technology and Product Dev...ed that Japan has recognized the uniqueness of Vir...
(Date:12/3/2009)..., ROTTERDAM, The Netherlands, December 3 /PR...ny focused on the discovery and development of hum...y(TM) platform, today,announced the successful sec.... The Company raised an additional EUR 3.0 million...investors, Credit Agricole Private Equity and,VIB ...
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com...ailable in its catalogue: ,, Cardiac Pacemake...eportlinker.com/p0164335/Cardiac-Pacemakers---A-Wo...constitute a major segment in a rapidly expanding ...ac pacemakers market is characterized by relativel...
Breaking Medicine Technology:VirtualScopics Receives Issuance in Japan of Prominent Patent 2VirtualScopics Receives Issuance in Japan of Prominent Patent 3arGEN-X Concludes EUR 12.5 Million Series A Financing Round 2arGEN-X Concludes EUR 12.5 Million Series A Financing Round 3arGEN-X Concludes EUR 12.5 Million Series A Financing Round 4Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 2Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 3Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 4Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 5Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 6Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 7Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 8Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 9Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 10ATS Medical Announces Third Quarter 2009 Earnings Release Date and Conference Call 5713 1ATS Medical Announces Third Quarter 2009 Earnings Release Date and Conference Call 5713 2MedPlus Maintains Top Ranking in KLAS Industry Report 5710 1MedPlus Maintains Top Ranking in KLAS Industry Report 5710 2MedPlus Maintains Top Ranking in KLAS Industry Report 5710 3MedPlus Maintains Top Ranking in KLAS Industry Report 5710 4Reportlinker Adds Outsourcing Preclinical Studies to China 5707 1Reportlinker Adds Outsourcing Preclinical Studies to China 5707 2Reportlinker Adds Outsourcing Preclinical Studies to China 5707 3Reportlinker Adds Outsourcing Preclinical Studies to China 5707 4Reportlinker Adds Outsourcing Preclinical Studies to China 5707 5Reportlinker Adds Outsourcing Preclinical Studies to China 5707 6
...r Similar to Seven-Day in, Achieving Red Blood Cel...t in All MDS Patients Tested...Hematology (ASH) Meeting, ATLANTA, Dec. 11 Pharm...nterim data from a Phase 2 clinical trial,evaluati... Vidaza(R),(azacitidine for injection) that demons...
...city With Equivalent Complete Re...erapeutics, Inc.,(CTI) (Nasdaq and MTAX: CTIC) ann...II/III randomized study comparing CPOP-R to CHOP-R...essive non-Hodgkin,s lymphoma,(NHL) showed patient...(grade 3/4) toxicities including severe infection ...
Other Medicine Technology:MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 2MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 3MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 4MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 5MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule 6Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 2Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 3Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 4Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 5
Multi Dop T1
EZ-Dop
...owerful automated system capable of handling any c...m 6 user-programmable test protocols to begin a fu...tests not included in the comprehensive list of au...ler, PVR and PPG instrument modes. Provides high f...
CD Horizon M10
Medicine Products: